A new, tougher test designed to curb the spread of the coronavirus that has infected more than 9.3 million people worldwide is being tested in Australia and New Zealand ahead of the start of the world health conference in Durban, South Africa on Monday.
The International Council on Behavioral Sciences (ICBS) said it will use the new test in a new study and that it will be distributed to clinicians in three countries: Australia, the United States and the United Kingdom.
The ICBS said it would test the test on a sample of people who have tested positive for the virus, and that more than 40 million people have tested negative for coronaviruses worldwide.
But the ICBS did not say how many of the tests it would use.
It did say that it would share data on the tests with health providers in Australia, United States, and the UK.
“The ICSB’s new, novel approach to testing will provide a more robust, and efficient, way to detect and reduce the spread and spread of COVID-19,” ICBS head Dr. Stephen F. Miller said in a statement.
“The results will help inform the development of new vaccines and diagnostics for COVID, and will enable the development and deployment of effective strategies for managing the pandemic.”
The test is being rolled out in three parts: a small, in-patient screening test, an outpatient testing test, and an online test.
The online test is only available to health care providers and does not use the ICSb’s technology.
The ICBC said the test will help determine if the person has COVID and to help detect COVID infections.
“In the short term, the IBSS will be using this test to detect those who have been in contact with people with coronaviral infection,” Dr. Andrew F. Knauss, the ICBC’s head of coronaviscosity, said in the statement.
“But we anticipate the IHS will expand the use of this test, to ensure that the test is used across all healthcare settings.”
“This will help us to monitor and manage the spread, as well as to reduce the risks to health-care workers,” he added.
The test will take less than a minute, and it will measure the virus in a lab, rather than in the body, which is easier to detect.
The IBSs new test is different from the tests used in the United Nations World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).
They have a specific focus on coronavids and are designed to be more sensitive to the virus.
Dr. James T. Thomas, a professor of infectious diseases and immunology at the Icahn School of Medicine at Mount Sinai, said the new tests would be a great way to make sure that coronavides are being detected.
“If you look at the WHO tests and they are very sensitive to COVIDs, they are not very effective in terms of slowing the spread.
This is a different test, so it is more sensitive, and hopefully that will help it be more effective in slowing the pandemics,” Dr Thomas said.
“We have a lot of data on coronas, but we don’t really know what is going on there.”
The ICbs said it has already been testing the new ICBS test on more than 6 million people and is in the process of testing a smaller sample of the population.
The ICBS will provide the testing to the WHO and CDC, and said it planned to release more information about the test soon.
Earlier this week, the World Health Assembly in Durham, South African, agreed to hold an emergency meeting to discuss how to fight the spread in the region, after coronavillosis was reported in 10 countries in South Africa.
The WHO said it was aware of the outbreak and was working closely with the ICbs.”ICBS is committed to providing the most comprehensive test for COVIS-19 to be deployed in all its parts in the world,” the WHO said in an email to The Associated Press.
In a statement, the CDC said the ICBbs test is the first of its kind.
“This test will provide an important benchmark for all health systems and will help to protect healthcare workers,” said Dr. Thomas.
“We look forward to sharing the results of this important research in the coming days.”
The World Health Organisation said that the ICBs test will not be used to test for the COVID virus.